New evidence supports menopausal hormone therapy for reducing mortality and enhancing healthspan, with updated guidelines emphasizing personalized approaches based on recent studies and expert insight...
New research reveals Ube2g1 upregulation in hematopoietic stem cells drives immune senescence via tyrosine phosphorylation, offering insights for reversing age-related decline, based on Haematologica ...
Emerging research links aging oral microbiome with senescent cells to amplify systemic inflammation, driving diseases like Alzheimer’s and offering new intervention targets such as probiotics an...
The ARMOR clinical trial investigates FMT from young, active donors to older adults to enhance muscle, cognitive, and metabolic health, addressing gut dysbiosis for aging resilience. A groundbreaking ...
Recent studies show that targeting engrams with partial reprogramming factors improves memory in mouse models, offering a potential therapy for Alzheimer’s and age-related cognitive decline. New...
New research on position effect variegation in Drosophila reveals epigenetic aging markers, linking heterochromatin stability to longevity and informing anti-aging therapies. Recent studies show PEV i...
A 2024 study in Nature Aging shows transferring young gut bacteria to aged mice rejuvenates intestinal stem cells via Wnt signaling, suggesting FMT’s potential for age-related disorders. Recent ...
Life Biosciences receives FDA clearance for the first human trial of cellular reprogramming targeting glaucoma and NAION, signaling regulatory openness to longevity therapies and potential vision rest...
Emerging senolytic treatments target cellular senescence to reduce inflammation and improve kidney function in diabetic patients, with recent clinical trials confirming safety and hinting at efficacy....
Recent studies show FMT from young donors improves gut health and cognitive function in aging, with FDA updates and probiotic innovations paving the way for scalable therapies. New research reveals FM...